Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS Pediatric Scaling Diseases: An Approach to Pediatric Psoriasis Next Steps in Dermatology Inflammatory skin march in atopic dermatitis and psoriasis Inflammation Research Springer Nature Link Real World Canadian Case Series: Use of Tildrakizumab for Moderate to Severe Psoriasis Psoriasis harbors multiple pathogenic type 17 T cell subsets: Selective modulation by risankizumab Journal of Allergy and Clinical Immunology